Table 2: Unadjusted and adjusted analysis
Mortality with different risk factors Dilla Ethiopia, 2014.
Variables |
UHR** |
95% CI*** |
AHR**** |
95% CI |
Gender |
|
|
|
|
Male
|
1 |
1 |
1 |
1 |
Female |
0.84 |
0.66-1.08 |
0.85 |
0.64-1.14 |
Age (per 1 year increase) |
1.02 |
1.01-1.03 |
1.02 |
1.01-1.03 |
Marital Status |
|
|
|
|
Married |
0.95 |
0.64-1.41 |
1.02 |
0.68-1.53 |
Never
Married |
1 |
1 |
1 |
1 |
Divorced
/Separated |
0.79 |
0.39-1.61 |
0.78 |
0.41-1.49 |
Widowed
|
0.84 |
0.47-1.49 |
0.93 |
0.51-1.70 |
Literacy Status |
|
|
|
|
Illiterate
|
1 |
1 |
1 |
1 |
Primary
|
1.18 |
0.73-1.64 |
1.07 |
0.72-1.60 |
Secondary
and above |
1.25 |
0.78-1.74 |
1.01 |
0.76-1.49 |
Baseline functional Status |
|
|
|
|
Ambulatory
|
1 |
1 |
1 |
1 |
Bedridden
|
3.06 |
2.08-4.49 |
2.60 |
1.73-3.92 |
Working
|
0.50 |
0.37-0.67 |
0.74 |
0.53-1.02 |
Baseline Weight (per 1 kg increase) |
0.97 |
0.95-0.98 |
0.97 |
0.96-0.99 |
WHO stage |
|
|
|
|
Stage
I |
1 |
1 |
1 |
1 |
Stage
II |
2.08 |
0.76-5.71 |
1.76 |
0.63-4.89 |
Stage
III |
3.38 |
1.35-8.45 |
2.17 |
0.82-5.31 |
Stage
IV |
7.11 |
2.77-18.25 |
2.77 |
1.14-7.26 |
CD4 count at baseline (per 1 unit increase) |
0.99 |
0.99-1.10 |
0.99 |
0.92-1.00 |
Hemoglobin (per 1g/dl increase) |
0.93 |
0.97-1.09 |
0.98 |
0.96-1.09 |
CPT initiation |
|
|
|
|
Before |
1 |
1 |
1 |
1 |
With
ART |
1.85 |
1.15-3.19 |
1.13 |
0.65-1.98 |
INH initiation |
|
|
|
|
NO |
1 |
1 |
1 |
1 |
Before
ART |
0.11 |
0.04-0.68 |
0.18 |
0.03-1.34 |
After
ART |
0.14 |
0.07-0.27 |
0.13 |
0.06-0.26 |
ART |
|
|
|
|
NO |
2.59 |
1.83-3.66 |
2.21 |
1.55-3.17 |
Yes |
1 |
1 |
1 |
1 |
UHR:
Unadjusted Hazard ratio; CI: Confidence Interval; AHR: Adjusted Hazard Ratio;
WHO: World Health Organization; CPT: Cotrimoxazole
Prophylaxis Treatment; IPT: Isoniazid Preventive Therapy ART: Antiretroviral Therapy